Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 14/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.36 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31423041 | 0.88 | CNR2 (0.41) | CNR2LMNAMEN1KMT2AHSD17B1 | |
| SCHEMBL31423269 | 0.88 | LMNA (0.42) | CNR2LMNAMEN1KMT2AHSD17B1 | |
| SCHEMBL31422934 | 0.87 | MEN1 (0.41) | CNR2LMNAMEN1KMT2AHSD17B1 | |
| SCHEMBL31422769 | 0.86 | LMNA (0.40) | CNR2LMNAMEN1KMT2AHSD17B1 | |
| SCHEMBL31422776 | 0.86 | LMNA (0.42) | CNR2LMNAMEN1KMT2AHSD17B1 | |
| SCHEMBL31423295 | 0.86 | LMNA (0.42) | CNR2LMNAMEN1KMT2AHSD17B1 | |
| SCHEMBL31422763 | 0.85 | LMNA (0.40) | CNR2LMNAMEN1KMT2AHSD17B1 | |
| SCHEMBL31422832 | 0.85 | LMNA (0.40) | CNR2LMNAMEN1KMT2AHSD17B1 | |
| SCHEMBL31422766 | 0.85 | KMT2A (0.39) | CNR2LMNAMEN1KMT2AHSD17B1 | |
| SCHEMBL31423325 | 0.85 | HSD17B2 (0.42) | CNR2LMNAMEN1KMT2AHSD17B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025085233-A1 | NOVEL DERIVATIVES OF QUINOLINONES, AND COMPOSITIONS AND METHODS THEREOF | ENSEM THERAPEUTICS, INC. (US) | 2025-04-24 | — | — | WO | disclosed |